Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol.
Holownia
Adam
A
Department of Clinical Pharmacology, Medical Academy of Bialystok, Bialystok, Poland. holow_sinai@hotmail.com
Trofimiuk
Emil
E
Krawczuk-Rybak
Maryna
M
Jakubow
Piotr
P
Kaliszewski
Jacek
J
Muszynska-Roslan
Katarzyna
K
Braszko
Jan J
JJ
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use*; D001215:Asparaginase / Q000494:pharmacology / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000134:cerebrospinal fluid; D002648:Child; D003630:Daunorubicin / Q000494:pharmacology / Q000627:therapeutic use*; D018846:Excitatory Amino Acids / Q000134:cerebrospinal fluid*; D018698:Glutamic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D011241:Prednisone / Q000494:pharmacology / Q000627:therapeutic use*; D014750:Vincristine / Q000494:pharmacology / Q000627:therapeutic use*; D016875:tau Proteins / Q000134:cerebrospinal fluid*
D018846:Excitatory Amino Acids; D016875:tau Proteins; D001224:Aspartic Acid; D018698:Glutamic Acid; D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin